MedTrace Logo

Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a

NCT01398774 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 519

Last updated 2018-08-22

No results posted yet for this study

Summary

The investigators would like to learn more about the metabolic consequences of pseudohypoparathyroidism type 1a in children, adolescents and adults with this condition. People with pseudohypoparathyroidism 1a are at risk for development of obesity. To better understand the cause of overweight or obesity, investigators are measuring body composition and resting energy expenditure (REE), which is the amount of calories burned while completely at rest. The investigators also want to determine the amount of body fat.

Conditions

  • Pseudohypoparathyroidism Type 1A
  • Albright Hereditary Osteodystrophy

Sponsors & Collaborators

Principal Investigators

  • Michael A Levine, M.D. · Children's Hospital of Philadelphia

Eligibility

Min Age
5 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-09-30
Completion
2017-11-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398774 on ClinicalTrials.gov